CMO Bruns Ingmar bought 20,000 shares of ZNTL at $2.28; stock now $2.16, down 86.6% from 52-week high
Chief Medical Officer Bruns Ingmar purchased 20,000 shares at $2.28 on 2025-02-06, more than doubling his post-transaction holdings to 36,629 shares from 16,629 shares. The stock is trading at a steep discount to its 52-week high of $16.13, currently down 86.6% from that peak and off 15.6% over the past 30 days. The company generated no revenue in its latest quarter and reported a net loss of $40,158,000.00, with unprofitability across its most recent full fiscal year. Notably, this purchase is part of a cluster pattern with 3 other insiders also buying within the past 14 days, suggesting coordinated action by company leadership during a period of severe stock decline and operational losses.